| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/03/22 | 8-K | Current report filing |
|
   |
3 |
| 06/01/22 | 8-K | Current report filing |
|
|
3 |
| 05/25/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/24/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/19/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/22 | 8-K | Current report filing |
|
|
12 |
| 04/13/22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 04/13/22 | DEF 14A | Definitive proxy statements |
|
37 | |
| 04/13/22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 04/11/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
36 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.